MacroGenics | MGNX - 売上総利益





売上総利益 変化する 日付
AbbVie USD 12.54B 474M 2026-03
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Biogen USD 1.82B 169.5M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Genmab DKK 977M 13M 2025-12
Geron USD 50.14M 3.44M 2026-03
Gilead Sciences USD 5.52B 791M 2026-03
J&J USD 18.55B 1.31B 2026-06
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
MacroGenics USD 11.24M 19.87M 2026-03
Merck USD 10.85B 2.57B 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.69B 600M 2026-06
Xencor USD 21M 22.61M 2025-09